Skip to main content
Filing year 2024

ACTION TO CURE KIDNEY CANCER

New York, New York·EIN 20-0441399·NTEE H12 · Medical Research·3
Total revenue
$10k
Total assets
$98k
Total expenses
$2k
Reported officers
2

Reported officers (all unpaid)

No paid executives reported in 2024. ACTION TO CURE KIDNEY CANCER reported 2 unpaid officers and board members on its 990-EZ.

President
Treasurer
Sector benchmark

What Medical Research executives earn in New York

ACTION TO CURE KIDNEY CANCER reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization in New York earns a median of $165,152.

25th percentile
$62k
Median
$165,152
75th percentile
$300k
90th percentile
$611k

These are medical research sector-wide figures, not this organization's reported pay. Based on 101 organizations across 101 filings (2022 – 2024).

See full Medical Research pay data for New York
FAQ

Common questions about ACTION TO CURE KIDNEY CANCER

What are ACTION TO CURE KIDNEY CANCER's revenue and expenses?

In 2024, ACTION TO CURE KIDNEY CANCER reported $10k in total revenue and $2k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.